Opioid Therapy–Associated Cardiovascular Effects
In patients taking prescribed opioids, an increased cardiovascular event rate has recently been reported in older adults..
Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Trends in Aspirin Use for Secondary Prevention of ASCVD
According to the CDC’s Behavioral Risk Factor Surveillance System 2013, nearly 71% of adults with atherosclerotic cardiovascular disease use aspirin regularly.
Understanding Cholesterol Therapy: An Update for Community Pharmacists
Elevated total and LDL cholesterol predispose patients to an increased risk of cardiovascular disease and mortality.
Malignant Hyperthermia: An Overview
Malignant hyperthermia must be treated rapidly to avoid fatality, and despite its rarity, healthcare facilities that use known triggering agents must be fully prepared to treat it.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.